Skip to comments.Obamacare vs. Drug Innovation
Posted on 02/16/2011 4:34:05 PM PST by Nachum
PhRMAs quiescence on Obamacare badly hurt the industry and all those who depend on medical innovation.
With the release of the presidents budget, it is now beyond dispute Beltway spin notwithstanding that the decision by the Pharmaceutical Research and Manufacturers of America (PhRMA) to support the health-care bill was one of the worst self-inflicted wounds in the history of lobbying. For biotech and pharmaceutical companies, the presidents budget repudiates one of the most important benefits of their deal with the White House: the ability to market biotech drugs without generic competition for twelve years. The president would reduce that period to seven years, precisely the position of the generics industry and a position that the pharmaceutical industry had fought aggressively before it decided to make a deal with the president.
(Excerpt) Read more at nationalreview.com ...
The list, ping
Let me know if you would like to be on or off the ping list
F Obama and F Pharma.
Both are going to kill millions with their dirty deal.
One, I didn’t know the president got to write or change the law. Two, this is why you(any industry) don’t get in bed with the government.
this is what happens when ya make a deal with the debbil.
Obama can’t do that with patent law (not even using executive orders), but can (and did) cajole Congress.
See how many lives will be lost when a new, lifesaving drug comes out, and you get an aspirin, or plain penicillin, because the government mandates it. Say goodbye to miracle drugs of the future.